Addex Therapeutics annual net debt
2018
2019
2020
2021
2022
2023
2024
2025
Addex Therapeutics Net Debt Growth & History (ADXN)
Addex Therapeutics's net debt was −CHF1.6M for fiscal 2025.
View full Addex Therapeutics company overviewAddex Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −CHF1.6M | CHF1.7M | — |
| 2024 | 2024-12-31 | −CHF3.3M | CHF221,401 | — |
| 2023 | 2023-12-31 | −CHF3.5M | CHF3.1M | — |
| 2022 | 2022-12-31 | −CHF6.6M | CHF13.4M | — |
| 2021 | 2021-12-31 | −CHF20.0M | −CHF1.9M | — |
| 2020 | 2020-12-31 | −CHF18.1M | CHF12.9M | — |
| 2019 | 2019-12-31 | −CHF31.0M | CHF550,245 | — |
| 2018 | 2018-12-31 | −CHF31.5M | — | — |
Addex Therapeutics quarterly net debt
Q4.19
Q4.20
Q4.21
Q4.22
Q2.23
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −CHF832,884 | CHF2.0M | — |
| Q4 2025 | 2025-12-31 | −CHF1.6M | CHF1.7M | — |
| Q3 2025 | 2025-09-30 | −CHF2.2M | — | — |
| Q2 2025 | 2025-06-30 | −CHF2.3M | — | — |
| Q1 2025 | 2025-03-31 | −CHF2.8M | — | — |
| Q4 2024 | 2024-12-31 | −CHF3.3M | CHF221,401 | — |
| Q4 2023 | 2023-12-31 | −CHF3.5M | CHF3.1M | — |
| Q2 2023 | 2023-06-30 | −CHF6.9M | — | — |
| Q4 2022 | 2022-12-31 | −CHF6.6M | CHF13.4M | — |
| Q4 2021 | 2021-12-31 | −CHF20.0M | −CHF1.9M | — |
| Q4 2020 | 2020-12-31 | −CHF18.1M | CHF12.9M | — |
| Q4 2019 | 2019-12-31 | −CHF31.0M | — | — |
Addex Therapeutics net debt trends
Over the last five fiscal years, Addex Therapeutics's net debt increased from −CHF18.1M to −CHF1.6M, a change of CHF16.5M. The latest reported quarter, Q1 2026, shows −CHF832,884.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Addex Therapeutics source filings ↗